Can pharmaceutical process development become high tech?

AIChE Journal

Volumn 52, Issue 12, 2006, Pages 3990-3994

  McKenzie, Paul ^a   Kiang, San ^a   Tom, Jean ^a   Erik Rubin, A ^a   Futran, Mauricio ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

cGMP; ISA S.88; Modeling; PAT; Pharmaceutical process development; QbD

Indexed keywords

EID: 33845586637     PISSN: 00011541     EISSN: 15475905     Source Type: Journal    
DOI: 10.1002/aic.11022     Document Type: Article

References (26)

1. New Prescription for Drug Makers: Update the Plants. Leila Aboud & Scott Henry. Wall Street Journal, September 12, 2003.
2. Basu P. Pharmaceutical Process Development is Different. Chem Eng Progress, Sept 1998; P75.
3. Karet G. Technology Systematizes Chemical Development. Drug Discovery & Development, Nov/Dec 2001, P26.
4. ISA, the Instrument, Systems and Automation society sponsored the creation of the S88 standards and supports the expansion and development of industrial instrumentation and control expertise for process and other industries.
5. st Century - A Risk-Based Approach. August 21, 2002
6. st Century - A Risk-Based Approach: Second Progress Report and Implementation Plan, February 20; 2003.
7. Food & Drug Administration, Guidance for Industry PAT - a Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance, September; 2004.
8. International Conference of Harmonization Handbook. Q8 Pharmaceutical Development, 2005.
9. Nasr Moheb. Risk-Based CMC Review and Quality Assessment: What is Quality by Design (QbD)? 2006; FDA/Industry Conference. Philadelphia, PA, March; 2006.
10. Lynn Craig. The ISA S.88 Standard: A Roadmap for Automation and a Powerful Management Tool; 2006. Source: Lynn Craig personal communication from training program 2005.
11. McKenzie P, Wasser, D., Schild, R., Fenn, A. S.88 is not just for Batch Anymore, OPX Conference. Philadelphia, PA; Aug 2006.
12. Schild R, Wasser, D. Data diving the S88 way - Using the EVT Interface and DataLink to Support Process Modeling, OS1 users Conference. San Francisco, CA. May; 2006.
13. Chen CC, Craft P. Correlation and prediction of drug molecule solubility in mixed solvent systems with the nonrandom two-liquid segment activity coefficient (NRTL-SAC) model. Ind Eng Chem Res. 2006;45:4816.
14. Kougoulos E, Jones AG, Wood-Kaczmar MW. Process modelling tools for continuous and batch organic crystallization processes including application to scale-up. Org. Process Res. Dev. 2006;10:739.
15. Nonoyama N, Hanaki K, Yabuki Y. Constant supersaturation control of antisolvent-addition batch crystallization. Org Process Res. Dev. 2006;10:727.
16. Bright R, Dale DJ, Dunn PJ, Hussain F, Kang Y, Mason C, Mitchell JC, Snowden MJ. Identification of new catalysts to promote imidazolide couplings and optimisation of reaction conditions using kinetic modelling. Org. Process Res. Dev. 2004;8:1072.
17. Rubin AE, Tummala S, Both DA, Wang C, Delaney E. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry. Chem Rev. 2006;106:2794-2810.
18. (a) Harre M, Tiltsam U, Weinmann H. Breaking the new bottleneck: automated synthesis in chemical process research and development. Org. Process Res. Dev. 1999;3:304.
19. (b) Emiabata-Smith D, Crookes DL, Owen MR. A practical approach to accelerated process screening and optimization. Org Process Res Dev. 1999;3:281.
20. (c) Van Loo ME, Lengowski PE. Automated workstations for parallel synthesis. Org Process Res. Dev. 2002;6; 833.
21. Morissette SL, Almarsson O, Peterson ML, Remenar JF, Read MJ, Lemmo AV, Ellis S, Cima MJ, Gardner CR. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv Drug Delivery Rev. 2004;56:275.
22. (a) Tan H, Semin D, Wacker M, Cheetham J. J Assoc Lab Automation. 2005;10:364.
23. (b) Dinter C, Schuetz A, Blume T, Weinmann H, Harre M, Neh H. Automated solubility determination using a customized robotic system and a turbidity probe. J Assoc Lab Automation. 2005;10:408.
24. (c) Rubin E. A Highly Impactful Solubility Determination Service for Process Scientists at Bristol-Myers Squibb, Presented at the 2005 Global Symyx-Intel-liChem User Group Meeting. Cambridge, MA; June 28-29, 2005.
25. (a) McWilliams C, Sidler DR, Sun Y, Mathre DJ. Applying statistical design of experiments and automation to the rapid optimization of metal-catalyzed processes in process development. J Assoc Lab Automation. 2005; 10:394.
26. (b) Mathre DJ. Operational Excellence: High-throughput Experimentation in Support of Pharmaceutical Development at Merck. Symyx Symposium 2006. Annapolis, Md; June 20-21; 2006.